Anida Pharma

Anida Pharma was founded in 2012, with the mission of developing new therapies to treat central nervous system disorders as well as hearing loss.

Its lead molecule, Neuroprotectin D1 (NPD1), is aimed at preventing drug induced hearing loss. It’s intended to be delivered locally to the inner ear as not to interfere with cisplatin chemotherapy.

Clinical trials to be announced.

RECENT NEWS ON ANIDA PHARMA

Nothing Found

Sorry, no posts matched your criteria

COMPANY OVERVIEW

Anida Pharma

Locations: United States
Year Founded: 2012
CEO: Per Gjorstrup (M.D. & Ph.D.)